dc.contributor.author | Hovland, Anders | |
dc.contributor.author | Mundal, Liv | |
dc.contributor.author | Igland, Jannicke | |
dc.contributor.author | Veierød, Marit Bragelien | |
dc.contributor.author | Holven, Kirsten Bjørklund | |
dc.contributor.author | Bogsrud, Martin Prøven | |
dc.contributor.author | Tell, Grethe S. | |
dc.contributor.author | Leren, Trond Paul | |
dc.contributor.author | Retterstøl, Kjetil | |
dc.date.accessioned | 2022-07-25T13:31:23Z | |
dc.date.available | 2022-07-25T13:31:23Z | |
dc.date.created | 2019-01-24T16:12:14Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Stroke. 2018, 50 (1), 172-174. | |
dc.identifier.issn | 0039-2499 | |
dc.identifier.uri | https://hdl.handle.net/11250/3008306 | |
dc.description.abstract | Familial hypercholesterolemia (FH) is a common autosomal dominant disease leading to increased level of serum LDL (low-density lipoprotein) cholesterol and risk of coronary heart disease. Whether FH increases the risk of cerebrovascular disease, including ischemic stroke, is debated. Accordingly, we studied the incidence of cerebrovascular disease in a cohort of people with genetically verified FH compared with the entire Norwegian population and examined whether people in this cohort with previous cohort had increased risk of cerebrovascular disease. | |
dc.language.iso | eng | |
dc.title | Risk of Ischemic Stroke and Total Cerebrovascular Disease in Familial Hypercholesterolemia. | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.description.version | acceptedVersion | |
dc.source.pagenumber | 172-174 | |
dc.source.volume | 50 | |
dc.source.journal | Stroke | |
dc.source.issue | 1 | |
dc.identifier.doi | 10.1161/STROKEAHA.118.023456 | |
dc.identifier.cristin | 1664655 | |
cristin.unitcode | 7502,3,2,0 | |
cristin.unitname | Avdeling for kroniske sykdommer og aldring | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.fulltext | postprint | |
cristin.qualitycode | 2 | |